(Q48216300)

9 February 2018

title

Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (English)

1 reference

9 February 2018

0 references

0 references

J A S Crippa

1

1 reference

9 February 2018

J E C Hallak

2

1 reference

9 February 2018

J P Machado-de-Sousa

3

1 reference

9 February 2018

R H C Queiroz

4

1 reference

9 February 2018

M Bergamaschi

5

1 reference

9 February 2018

M H N Chagas

6

1 reference

9 February 2018

A W Zuardi

7

1 reference

9 February 2018

publication date

24 October 2012

1 reference

9 February 2018

Journal of Clinical Pharmacy and Therapeutics

published in

1 reference

9 February 2018

volume

38

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

162-164

1 reference

9 February 2018

The cannabis withdrawal syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Review of the validity and significance of cannabis withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Pharmacotherapy for cannabis dependence: how close are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Cannabinoid tolerance and dependence: a review of studies in laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Marijuana dependence and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Cannabis and anxiety: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Effects of cannabidiol (CBD) on regional cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Antianxiety effect of cannabidiol in the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Hypnoticlike effects of cannabidiol in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Controlled clinical trial of cannabidiol in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Comparative study of drug use among undergraduate students at the University of São Paulo--São Paulo campus in 1996 and 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Marijuana abstinence effects in marijuana smokers maintained in their home environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

The endocannabinoid system as a target for the treatment of cannabis dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12018

21 January 2018

Identifiers

DOI

10.1111/JCPT.12018

1 reference

9 February 2018

release_a3zxzxhdljhkriyiytytb2l4xy

Fatcat ID

0 references

1 reference

9 February 2018